Sanofi's BTK inhibitor Wayrilz has become the first drug in the class to be approved by the FDA for immune thrombocytopenia (ITP), a rare autoimmune blood disorder. Wayrilz (rilzabrutinib) has been ...

Spain’s ITP Aero is ramping up production at its UK site of combustors for Pratt & Whitney PW1500G/1900G engines having shipped the first unit in late December. That delivery marks a significant ...

DEAR DR. ROACH: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...

Dear Dr. Roach: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...

There is great entertainment value in sport: from the thrill of competitive contests between people at the peak of their game, to the adrenaline-fuelled rollercoaster that comes with following your ...

The acquisition is expected to close during the first half of 2026 Aero Norway is based in Stavanger, Norway ITP Aero is an aerospace propulsion company ITP Aero, which is owned by Bain Capital, has ...

ITP Aero is to further reinforce its growing MRO business with the acquisition of Stavanger-based Aero Norway. Specialising in the repair and overhaul of CFM International CFM56 engines, the Norwegian ...

ITP Aero has signed a binding agreement to acquire CFM56 engine repair specialist Aero Norway with the deal expected to be finalized in the first half of 2026 subject to approvals. Bilbao-based ITP ...

There's a Honda coupe back in the world; as if any excuse was needed to remember the very best... Honda can go two ways with the Prelude, it seems. The car can remain as a rare groove hybrid ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

An expert discusses how current immune thrombocytopenia (ITP) treatments such as corticosteroids, rituximab, and fostamatinib have significant tolerability issues and fail to provide sustained ...

While Sanofi originally had its eye on tolebrutinib when it purchased its partner Principia Biopharma for $3.7 billion five years ago, another one of the Bruton tyrosine kinase (BTK) inhibitors ...